ERD

A multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease

Full project page

Organisations map overview

UNIVERSITE CATHOLIQUE DE LOUVAIN (UCL) - (Coördinator)

Country:

AZIENDA OSPEDALIERA PAPA GIOVANNI XXIII

Country:

Associação para Investigação e Desenvolvimento da Faculdade de Medicina

Country:

CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES

Country:

CENTRO HOSPITALAR LISBOA NORTE EPE

Country:

CHARITE - UNIVERSITAETSMEDIZIN BERLIN

Country:

CLINIQUE UNIVERSITAIRE SAINT-LUC ASBL

Country:

ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK

Country:

ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON

Country:

FONDAZIONE PER LA RICERCA OSPEDALE MAGGIORE DE BERGAMO

Country:

KKS-NETZWERK EV -NETZWERK DER KOORDINIERUNGSZENTREN FUR KLINISCHE STUDIEN

Country:

KLINIKUM DER UNIVERSITAET ZU KOELN

Country:

PANEPISTIMIAKO GENIKO NOSOKOMEIO ATTIKON

Country:

SOCIETE EUROPEENNE DE CARDIOLOGIE

Country:

SPRM - SOCIEDADE PORTUGUESA DE RESSONANCIA MAGNETICA SA

Country:

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

Country:

UNIVERSITAET LEIPZIG

Country:

UNIVERSITAETSMEDIZIN GOETTINGEN - GEORG-AUGUST-UNIVERSITAET GOETTINGEN - STIFTUNG OEFFENTLICHEN RECHTS

Country:

UNIVERSITATKLINIKUM LEIPZIG

Country:

UNIWERSYTET MEDYCZNY IM PIASTOW SLASKICH WE WROCLAWIU

Country: